Palestrantes | Speakers
Palestrantes Confirmados / Speakers
Dr. Sylvain Brisse
Sylvain Brisse is a researcher at Institute Pasteur (Paris, France), heading the Biodiversity and Epidemiology of Bacterial Pathogens laboratory.
“Previously controlled bacterial infections can re-emerge due to antibiotic resistance or vaccine escape. Species of pathogenic bacteria comprise a huge amount of genotypic and phenotypic diversity. Our lab is interested in the diversity, evolution and epidemiology of bacterial pathogens and in the links between the genotypic and phenotypic (ecology, colonization, transmission, virulence, antibiotic resistance, immune response) diversity of the strains within particular species. We focus on three pathogens of high public health importance: Klebsiella pneumoniae, which causes various types of infections including urinary tract, respiratory and blood infections; Bordetella pertussis, the agent of whooping cough; and Corynebacterium diphtheriae, the agent of diphtheria. We use genomics, proteomics, bioinformatics and immunological approaches as well as in-vivo and in-vitro models of infection. We also develop databases of bacterial genotypes and strain nomenclatures that facilitate global collaborative surveillance of bacterial pathogens”
For more information: https://research.pasteur.fr/en/team/biodiversity-and-epidemiology-of-bacterial-pathogens/
Dra Ana Gales
Great experience in the field of Infectious Diseases, with an emphasis on bacterial resistance. Professor, coordinator of the Postgraduate Program in Infectology, researcher, director of the Alert Laboratory and the Special Laboratory of Clinical Microbiology of Escola Paulista de Medicina / UNIFESP, Research Productivity Scholarship CNPq level 1A. Coordinator of the Brazilian Antimicrobial Sensitivity Test Committee (BrCast) and member of the Technical Chamber of Microbial Resistance (CATREM), ANVISA.
Dr Felipe Piedade Gonçalves Neves
Large experience in Applied Microbiology and Public Health. Research Productivity Scholarship - CNPq Level 2 and Young Scientist from Nosso Estado (FAPERJ). Prof. Associated of the Department of Microbiology and Parasitology of the Biomedical Institute of the Universidade Federal Fluminense (UFF). Coordinator of the Graduate Program in Applied Microbiology and Parasitology (PPGMPA / UFF).
Leah Cowen, PhD.
Professor and Chair of the Molecular Genetics Department at the University of Toronto, Canada. Her research focuses on developing new strategies to combat drug resistance and treat life-threatening fungal infections through an innovative and interdisciplinary approach, including chemical and functional genomics, experimental evolution, microbiome analysis of patient populations and structure-guided drug design. She has been recognized with a myriad of awards including a Burroughs Wellcome Fund Career Award, Grand Challenges Canada Star in Global Health Award, Merck Irving S. Sigal Memorial Award and E.W.R. Steacie Award.
Marcio Rodrigues, PhD.
Senior Researcher of Carlos Chagas Institute at FIOCRUZ Paraná in Brazil and a Coordinator of its Stricto Sensu Postgraduate Program in Biosciences and Biotechnology. He is a member of the American Academy of Microbiology and the Advisory Committee on Microbiology and Parasitology of CNPq. He is an advisor to the American Society of Medical Mycology, and a board member of the Brazilian Society of Microbiology. He has got a CNPq Research Productivity Scholarship, level 1B. His research group focuses on the mechanisms of non-conventional secretion in yeasts, aiming at the development of new antifungal drugs and prophylactic tools.
Leila Bezerra, PhD.
Founder and Researcher of the Startup BIDiagnostics at the Center for Innovation, Entrepreneurship and Technology, University of São Paulo (USP), through FAPESP Innovative Research Program for Small Businesses. She is a USP Visiting Researcher as FAPESP fellowship and Coordinator of the Working Group on Sporothrix and Sporotrichosis of the International Society for Human and Animal Mycology. She has got a CNPq Research Productivity Scholarship, level 1C and coordinates the INCT Emerging Fungal Infections. Her main goals include applied microbiology and mycosis immunodiagnosis.
Kelly Ishida, PhD.
Professor and the Leader of Antifungal Chemotherapy Laboratory in the Department of Microbiology at the University of São Paulo (USP), Brazil. She is a Coordinator of Antifungal Subcommittee of Brazilian Committee on Antimicrobial Susceptibility Testing (BrCAST). She has got a CNPq Research Productivity Scholarship, level 2 and her main Lab goals are to develop therapeutic alternatives for fungal infections approaching molecules of natural and synthetic origin, repositioning of drugs and production of drug carriers.
Alejandro Buschiazzo (Institute Pasteur, Montevideo) is a structural biologist whose work integrates molecular biology and protein biochemistry to understand mechanisms regulating pathogenesis in several organisms, including M. tuberculosis and Leptospira. He is head of the Molecular and Structural Microbiology Laboratory and of the Protein Crystallography Unit, as well as Associate Professor at the Microbiology Department at Institut Pasteur (Paris). Alejandro has been awarded several awards, including the François Jacob Prize (Institut Pasteur Paris, 2014), and is a member of the National Academy of Sciences of Uruguay and of the IUC´s Commission of Biological Macromolecules.
Douglas McIntosh (UFRRJ)
Professor of Molecular Biology at the Department of Animal Parasitology (DPA) at the Federal Rural University of Rio de Janeiro (UFRRJ). Its general area of research is the development of improved methods for the diagnosis and prevention of microbial and parasitic diseases considered relevant in the context of One Health.
Dr. Iñaki Comas (Biomedicine Institute of Valencia) :
Dr. Iñaki Comas is Head of the Tuberculosis Genomics Unit at the Biomedicine Institute of Valencia. Dr. Comas did his PhD at the University of Valencia on Evolutionary Genomics of bacteria. In 2008, he moved to Dr. Sebastien Gagneux's laboratory in the National Institute for Medical Research in London. His team was among the first to use genome sequencing in a large scale to address issues related to host-pathogen interaction, evolution, and drug resistance. In 2012, Dr. Comas returned to Spain and since 2016 holds a permanent principal investigator position at the Biomedicine Institute of Valencia. He has regional, national, and international funding including an ERC Starting Grant focusing on tuberculosis transmission. Current projects at the Tuberculosis Genomics Unit (http://tgu.ibv.csic.es/) cover basic, applied and clinical/translational research with major focus on transmission and drug resistance of tuberculosis. Analyses from his group led to breakthrough insights in our understanding of antigenic variation (Nat Genet. 2010), identification of drug resistance targets (Nat Genet. 2012, JID 2019), evolution with the human host (Nat Genet. 2013, PNAS 2015, Current Biology 2015), identification of genomic determinants of virulence (Chiner-Oms 2019, Science Advances) and on the transmission of the disease (JID 2014, EBIOMedicine 2018).
Dr. Fabrizio Menardo (SwissTPH):
He studied Natural sciences and environmental biology at the University of Torino (Italy). Then, moved to Switzerland to do his PhD in evolutionary Biology at the University of Zurich, in the group of Prof Beat Keller. During the PhD he researched the evolution of a fungal pathogen of wheat and other cereals (Blumeria graminis, grass powdery mildew). After the PhD he moved to Basel (Switzerland) for a PostDoc at the SwissTPH in the group of Prof Sebastien Gagneux, where he is currently working. Currently, he focus is on the population genetics, genomics and evolution of Mycobacterium tuberculosis.
Dr. Silvana Spíndola (UFMG)
Graduated in Medicine from the Faculty of Medicine of Valença (1988), Master in Medical Clinic Emphasis in Pulmonology and Phthisiology from the Federal University of Rio de Janeiro (1994), and PhD in Genie Biologique Medicale - Université Joseph Fourier - Grenoble I- France (1997). Post-doctorate at the Pasteur Institute in Paris (2006) at the Genetique Micobacterienne Laboratory. Collaborator at the Pontifical Catholic University of Rio Grande do Sul, Université Paris-Sud, State Foundation for Health Research and Production, Federal University of Rio Grande, Municipal Health Secretariat of Minas Gerais, Municipal Health Secretariat of Belo Horizonte, Fundação Ezequiel Dias and Federal University of Rio de Janeiro. Full professor at the Federal University of Minas Gerais, supervisor of the graduate course Adult Health and Tropical Health at the Federal University of Minas Gerais.
Experience in Medicine, with emphasis on Tuberculosis, acting on the following subjects: tuberculosis, phenotypic and genotypic diagnosis of mycobacteria, Mycobacterium tuberculosis, molecular epidemiology. Coordinator of the Laboratory of Mycobacteria of the Faculty of Medicine and of the Tuberculosis Clinic, a secondary reference at the Hospital das Clínicas, UFMG. Coordinator of the Diagnostic area REDE TB.
Fernanda C de Q Mello - MD, MSc, PhD
Full Professor at the Faculty of Medicine of the Federal University of Rio de Janeiro (UFRJ). Director of the Institute of Chest Diseases (IDT) at UFRJ. President of the Society of Pulmonology and Tisiology of the State of Rio de Janeiro (SOPTERJ). Experience in the area of Tisiology and Pulmonology, with projects related to diseases of the respiratory system covering epidemiological aspects, molecular biology, laboratory and radiological diagnosis and clinical trials, with an emphasis on tuberculosis and non-tuberculous mycobacteriosis.
Sylvain Brisse is a researcher at Institute Pasteur (Paris, France), heading the Biodiversity and Epidemiology of Bacterial Pathogens laboratory.
“Previously controlled bacterial infections can re-emerge due to antibiotic resistance or vaccine escape. Species of pathogenic bacteria comprise a huge amount of genotypic and phenotypic diversity. Our lab is interested in the diversity, evolution and epidemiology of bacterial pathogens and in the links between the genotypic and phenotypic (ecology, colonization, transmission, virulence, antibiotic resistance, immune response) diversity of the strains within particular species. We focus on three pathogens of high public health importance: Klebsiella pneumoniae, which causes various types of infections including urinary tract, respiratory and blood infections; Bordetella pertussis, the agent of whooping cough; and Corynebacterium diphtheriae, the agent of diphtheria. We use genomics, proteomics, bioinformatics and immunological approaches as well as in-vivo and in-vitro models of infection. We also develop databases of bacterial genotypes and strain nomenclatures that facilitate global collaborative surveillance of bacterial pathogens”
For more information: https://research.pasteur.fr/en/team/biodiversity-and-epidemiology-of-bacterial-pathogens/
Dra Ana Gales
Great experience in the field of Infectious Diseases, with an emphasis on bacterial resistance. Professor, coordinator of the Postgraduate Program in Infectology, researcher, director of the Alert Laboratory and the Special Laboratory of Clinical Microbiology of Escola Paulista de Medicina / UNIFESP, Research Productivity Scholarship CNPq level 1A. Coordinator of the Brazilian Antimicrobial Sensitivity Test Committee (BrCast) and member of the Technical Chamber of Microbial Resistance (CATREM), ANVISA.
Dr Felipe Piedade Gonçalves Neves
Large experience in Applied Microbiology and Public Health. Research Productivity Scholarship - CNPq Level 2 and Young Scientist from Nosso Estado (FAPERJ). Prof. Associated of the Department of Microbiology and Parasitology of the Biomedical Institute of the Universidade Federal Fluminense (UFF). Coordinator of the Graduate Program in Applied Microbiology and Parasitology (PPGMPA / UFF).
Leah Cowen, PhD.
Professor and Chair of the Molecular Genetics Department at the University of Toronto, Canada. Her research focuses on developing new strategies to combat drug resistance and treat life-threatening fungal infections through an innovative and interdisciplinary approach, including chemical and functional genomics, experimental evolution, microbiome analysis of patient populations and structure-guided drug design. She has been recognized with a myriad of awards including a Burroughs Wellcome Fund Career Award, Grand Challenges Canada Star in Global Health Award, Merck Irving S. Sigal Memorial Award and E.W.R. Steacie Award.
Marcio Rodrigues, PhD.
Senior Researcher of Carlos Chagas Institute at FIOCRUZ Paraná in Brazil and a Coordinator of its Stricto Sensu Postgraduate Program in Biosciences and Biotechnology. He is a member of the American Academy of Microbiology and the Advisory Committee on Microbiology and Parasitology of CNPq. He is an advisor to the American Society of Medical Mycology, and a board member of the Brazilian Society of Microbiology. He has got a CNPq Research Productivity Scholarship, level 1B. His research group focuses on the mechanisms of non-conventional secretion in yeasts, aiming at the development of new antifungal drugs and prophylactic tools.
Leila Bezerra, PhD.
Founder and Researcher of the Startup BIDiagnostics at the Center for Innovation, Entrepreneurship and Technology, University of São Paulo (USP), through FAPESP Innovative Research Program for Small Businesses. She is a USP Visiting Researcher as FAPESP fellowship and Coordinator of the Working Group on Sporothrix and Sporotrichosis of the International Society for Human and Animal Mycology. She has got a CNPq Research Productivity Scholarship, level 1C and coordinates the INCT Emerging Fungal Infections. Her main goals include applied microbiology and mycosis immunodiagnosis.
Kelly Ishida, PhD.
Professor and the Leader of Antifungal Chemotherapy Laboratory in the Department of Microbiology at the University of São Paulo (USP), Brazil. She is a Coordinator of Antifungal Subcommittee of Brazilian Committee on Antimicrobial Susceptibility Testing (BrCAST). She has got a CNPq Research Productivity Scholarship, level 2 and her main Lab goals are to develop therapeutic alternatives for fungal infections approaching molecules of natural and synthetic origin, repositioning of drugs and production of drug carriers.
Alejandro Buschiazzo (Institute Pasteur, Montevideo) is a structural biologist whose work integrates molecular biology and protein biochemistry to understand mechanisms regulating pathogenesis in several organisms, including M. tuberculosis and Leptospira. He is head of the Molecular and Structural Microbiology Laboratory and of the Protein Crystallography Unit, as well as Associate Professor at the Microbiology Department at Institut Pasteur (Paris). Alejandro has been awarded several awards, including the François Jacob Prize (Institut Pasteur Paris, 2014), and is a member of the National Academy of Sciences of Uruguay and of the IUC´s Commission of Biological Macromolecules.
Douglas McIntosh (UFRRJ)
Professor of Molecular Biology at the Department of Animal Parasitology (DPA) at the Federal Rural University of Rio de Janeiro (UFRRJ). Its general area of research is the development of improved methods for the diagnosis and prevention of microbial and parasitic diseases considered relevant in the context of One Health.
Dr. Iñaki Comas (Biomedicine Institute of Valencia) :
Dr. Iñaki Comas is Head of the Tuberculosis Genomics Unit at the Biomedicine Institute of Valencia. Dr. Comas did his PhD at the University of Valencia on Evolutionary Genomics of bacteria. In 2008, he moved to Dr. Sebastien Gagneux's laboratory in the National Institute for Medical Research in London. His team was among the first to use genome sequencing in a large scale to address issues related to host-pathogen interaction, evolution, and drug resistance. In 2012, Dr. Comas returned to Spain and since 2016 holds a permanent principal investigator position at the Biomedicine Institute of Valencia. He has regional, national, and international funding including an ERC Starting Grant focusing on tuberculosis transmission. Current projects at the Tuberculosis Genomics Unit (http://tgu.ibv.csic.es/) cover basic, applied and clinical/translational research with major focus on transmission and drug resistance of tuberculosis. Analyses from his group led to breakthrough insights in our understanding of antigenic variation (Nat Genet. 2010), identification of drug resistance targets (Nat Genet. 2012, JID 2019), evolution with the human host (Nat Genet. 2013, PNAS 2015, Current Biology 2015), identification of genomic determinants of virulence (Chiner-Oms 2019, Science Advances) and on the transmission of the disease (JID 2014, EBIOMedicine 2018).
Dr. Fabrizio Menardo (SwissTPH):
He studied Natural sciences and environmental biology at the University of Torino (Italy). Then, moved to Switzerland to do his PhD in evolutionary Biology at the University of Zurich, in the group of Prof Beat Keller. During the PhD he researched the evolution of a fungal pathogen of wheat and other cereals (Blumeria graminis, grass powdery mildew). After the PhD he moved to Basel (Switzerland) for a PostDoc at the SwissTPH in the group of Prof Sebastien Gagneux, where he is currently working. Currently, he focus is on the population genetics, genomics and evolution of Mycobacterium tuberculosis.
Dr. Silvana Spíndola (UFMG)
Graduated in Medicine from the Faculty of Medicine of Valença (1988), Master in Medical Clinic Emphasis in Pulmonology and Phthisiology from the Federal University of Rio de Janeiro (1994), and PhD in Genie Biologique Medicale - Université Joseph Fourier - Grenoble I- France (1997). Post-doctorate at the Pasteur Institute in Paris (2006) at the Genetique Micobacterienne Laboratory. Collaborator at the Pontifical Catholic University of Rio Grande do Sul, Université Paris-Sud, State Foundation for Health Research and Production, Federal University of Rio Grande, Municipal Health Secretariat of Minas Gerais, Municipal Health Secretariat of Belo Horizonte, Fundação Ezequiel Dias and Federal University of Rio de Janeiro. Full professor at the Federal University of Minas Gerais, supervisor of the graduate course Adult Health and Tropical Health at the Federal University of Minas Gerais.
Experience in Medicine, with emphasis on Tuberculosis, acting on the following subjects: tuberculosis, phenotypic and genotypic diagnosis of mycobacteria, Mycobacterium tuberculosis, molecular epidemiology. Coordinator of the Laboratory of Mycobacteria of the Faculty of Medicine and of the Tuberculosis Clinic, a secondary reference at the Hospital das Clínicas, UFMG. Coordinator of the Diagnostic area REDE TB.
Fernanda C de Q Mello - MD, MSc, PhD
Full Professor at the Faculty of Medicine of the Federal University of Rio de Janeiro (UFRJ). Director of the Institute of Chest Diseases (IDT) at UFRJ. President of the Society of Pulmonology and Tisiology of the State of Rio de Janeiro (SOPTERJ). Experience in the area of Tisiology and Pulmonology, with projects related to diseases of the respiratory system covering epidemiological aspects, molecular biology, laboratory and radiological diagnosis and clinical trials, with an emphasis on tuberculosis and non-tuberculous mycobacteriosis.